High expression of Aldolase A predicts poor survival in patients with clear-cell renal cell carcinoma

BACKGROUND: Aldolase A (ALDOA) is a glycolytic enzyme that drives the glycolytic metabolic pathway in mammalian cells. The overexpression of ALDOA was observed in a variety of cancers including clear-cell renal cell carcinoma (ccRCC). However, little was known about the clinicopathological significa...

Descripción completa

Detalles Bibliográficos
Autores principales: Na, Ning, Li, Heng, Xu, Chengfang, Miao, Bin, Hong, Liangqing, Huang, Zhengyu, Jiang, Qiu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5338975/
https://www.ncbi.nlm.nih.gov/pubmed/28280347
http://dx.doi.org/10.2147/TCRM.S123199

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5338975/
https://www.ncbi.nlm.nih.gov/pubmed/28280347
http://dx.doi.org/10.2147/TCRM.S123199

Ejemplares similares